Susquehanna International Group
WHWK

Susquehanna International Group’s Whitehawk Therapeutics WHWK Stock Holding History

Susquehanna International Group’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-31,300
Closed -$402K – 13657
2022
Q4 		$402K Sell
31,300
-40,300
-56% -$526K ﹤0.01% 8381
2022
Q3 		$1.01M Sell
71,600
-7,700
-10% -$101K ﹤0.01% 6612
2022
Q2 		$977K Buy
79,300
+25,100
+46% +$373K ﹤0.01% 6586
2022
Q1 		$920K Buy
+54,200
New +$1.04M ﹤0.01% 7336

Other funds holding WHWK

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $134M AUM
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

Susquehanna International Group's WHWK Position: Q1 2026 in Review

Susquehanna International Group increased its Whitehawk Therapeutics (WHWK) stake by 85% in Q1 2026, buying an estimated $292K and bringing the position to 203,465 shares worth $702K. The position accounts for ﹤0.01% of the portfolio, ranked #8809.

Susquehanna International Group first reported a position in WHWK in Q4 2021 and has held it in 14 quarters since. The position peaked at $1.64M in Q1 2022. 62 funds tracked by Wall St. Rank hold WHWK as of Q1 2026.

  • Susquehanna International Group held 203,465 shares of Whitehawk Therapeutics worth $702K as of Q1 2026.
  • Susquehanna International Group bought 93,382 Whitehawk Therapeutics shares in Q1 2026, an estimated $292K.
  • Whitehawk Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #8809 holding.
  • Susquehanna International Group first reported a position in Whitehawk Therapeutics in Q4 2021 and has held it in 14 quarters since.
  • Susquehanna International Group's Whitehawk Therapeutics position peaked at $1.64M in Q1 2022.
  • 62 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.